Abstract:BackgroundDetachment of epithelial cells from the extracellular matrix initiates programmed cell death by a process termed anoikis. Malignant cells must acquire anoikis resistance to leave the primary tumour and metastasise. Multiple signal transduction pathways can activate anoikis and confer anoikis resistance, but these are not understood in breast cancer.MethodsModels for anoikis of oestrogen-responsive breast cancer cells were established and the protective effects of IGF-1 tested. Cleaved PARP was measured by western transfer and cleaved caspase 3 by flow cytometry. Pathways involved in anoikis and in anoikis resistance were investigated with PI3-kinase, Akt, and MEK1 and MEK2 inhibitors. The importance of the type I IGF receptor was investigated by IGF-concentration dependence, siRNA knockdown and pharmacological inhibition. Association between IGF-1R expression and relapse with distant metastasis was analysed in 1609 patients by log rank test.ResultsUnattached breast cancer cells required culture in serum-free medium to induce anoikis. Rapid loss of FAK, Akt and Bad phosphorylation was concurrent with anoiks induction, but ERK1 and ERK2 phosphorylation increased which suggested that anoikis resistance is mediated by the PI3-kinase/Akt rather than the Grb2/Ras/MAP-kinase pathway. IGF-1 conferred anoikis resistance in serum-free medium. IGF-1 activated the PI3-kinase/Akt and Grb2/Ras/MAP-kinase pathways but experiments with PI3-kinase, Akt and MEK1 and MEK2 inhibitors showed that IGF protection is via the PI3-kinase/Akt pathway. The concentration dependence of IGF protection, knockdown experiments with siRNA and pharmacological inhibition with figitumumab, showed that IGF-1 signals through the type I IGF receptor. The crucial role of the type I IGF receptor was demonstrated by induction of anoikis in full serum by figitumumab. High IGF-1R expression was associated with reduced time to relapse with distant metastases in oestrogen receptor-positive patients, especially those with aggressive disease which confirms its relevance in vivo.ConclusionsAnoikis resistance of oestrogen-responsive breast cancer cells depends upon IGF activation of the type I IGF receptor and PI3-kinase/Akt pathway. Because IGF-dependent evasion of anoikis will facilitate metastasis by malignant breast cancer cells, effective inhibition of IGF signal transduction should be included in combinations of targeted drugs designed to treat metastatic oestrogen receptor-positive breast cancers.

Multiple Signaling Pathways of the Insulin-Like Growth Factor 1 Receptor in Protection from Apoptosis

Major Physiological Signaling Pathways in the Regulation of Cell Proliferation and Survival

Insulin-like growth factors are essential to prevent anoikis in oestrogen-responsive breast cancer cells: importance of the type I IGF receptor and PI3-kinase/Akt pathway

A novel role for IGF-1R in p53-mediated apoptosis through translational modulation of the p53-Mdm2 feedback loop

Inhibition of Src-like Kinases Reveals Akt-dependent and -Independent Pathways in Insulin-like Growth Factor I-mediated Oligodendrocyte Progenitor Survival

Overexpression of insulin receptor substrate-1, but not insulin receptor substrate-2, protects a T cell hybridoma from activation-induced cell death.

Overexpression of Insulin Receptor Substrate-1, But Not Insulin Receptor Substrate-2, Protects a T Cell Hybridoma from Activation-Induced Cell Death1

Targeting a novel apoptotic pathway in human disease

The Molecular Mechanism Of Endoplasmic Reticulum Stress-Induced Apoptosis In Pc-12 Neuronal Cells: The Protective Effect Of Insulin-Like Growth Factor I

Signaling pathways mediating anti-apoptotic action of neurotrophins

Role of Insulin-Like Growth Factor-1 (IGF-1) in Regulating Cell Cycle Progression

The Cardioprotection of the Insulin-Mediated PI3K/Akt/mTOR Signaling Pathway

Insulin-like Growth Factor Factor Binding Protein-2 is a Novel Mediator of P53 Inhibition of Insulin-Like Growth Factor Signaling.

IGF-1R inhibition induces MEK phosphorylation to promote survival in colon carcinomas

A redox-sensitive pathway mediates oxidized LDL-induced downregulation of insulin-like growth factor-1 receptor

The Essential Role of the Death Domain Kinase Receptor-interacting Protein in Insulin Growth Factor-I-induced C-Jun N-terminal Kinase Activation

Insulin-like growth factor-1 receptor (IGF-1R) kinase inhibitors in cancer therapy: advances and perspectives.

Inhibition of the PI 3-kinase pathway disrupts the unfolded protein response and reduces sensitivity to ER stress-dependent apoptosis

Apoptosis Inhibitor 5: A Multifaceted Regulator of Cell Fate

Irs-2, but Not Irs-1, Can Sustain Proliferation and Rescue Ubf Stabilization in Inr or Inr Defective Signaling of 32d Myeloid Cells

Effects of Insulin-Like Growth Factor-1 on the Proliferation, Apoptosis and MAPK Signaling Pathway of Rat Colonic Smooth Muscle Cells